Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan

Huan He, Carol L. Nilsson, Mark Emmett, Yongjie Ji, Alan G. Marshall, Roger A. Kroes, Joseph R. Moskal, Howard Colman, Frederick F. Lang, Charles A. Conrad

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We report changes in gene and polar lipid expression induced by adenovirus-delivered wild-type (wt) p53 gene and chemotherapy of U87 MG glioblastoma cells, a treatment known to trigger apoptosis and cell cycle arrest. Sulfatides (sulfonated glycolipids) were most highly modulated by wild-type p53 treatment; however, no changes were observed in expression levels of mRNA for genes involved in sulfatide metabolism, indicating post-transcriptional control of sulfatide synthesis. Modulation of the aglycones of GD1 and GM1b was observed in wild-type p53-treated cells. The treatment also leads to an increase in phospholipids such as phosphatidyl inositols, phosphatidyl serines, phosphatidyl glycerols, and phosphatidyl ethanolamines, especially hydroxylated phospholipids. These dramatic changes in the composition of cellular glycolipids in response to p53 gene expression and cytotoxic chemotherapy treatment indicate the large role that they play in cell signaling. The use of the human glioma cell line U87 appears to be an excellent model system both in tissue culture and in intracranial murine xenograft models to further characterize the role of sulfatides in modulating glioma responsivity to therapeutic agents.

Original languageEnglish (US)
Pages (from-to)27-38
Number of pages12
JournalGlycoconjugate Journal
Volume27
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

irinotecan
Topoisomerase I Inhibitors
Sulfoglycosphingolipids
Glioma
Lipids
Chemotherapy
Genes
Glycolipids
Cells
p53 Genes
Phospholipids
Ethanolamines
Cell signaling
Tissue culture
Phosphatidylglycerols
Phosphatidylserines
Therapeutics
Drug Therapy
Phosphatidylinositols
Heterografts

Keywords

  • Fourier transform ion cyclotron resonance mass spectrometry
  • Galectin-1
  • Glioblastoma
  • Glycolipids
  • Lipidomics
  • Microarrays
  • Phospholipids
  • Sulfatides

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan. / He, Huan; Nilsson, Carol L.; Emmett, Mark; Ji, Yongjie; Marshall, Alan G.; Kroes, Roger A.; Moskal, Joseph R.; Colman, Howard; Lang, Frederick F.; Conrad, Charles A.

In: Glycoconjugate Journal, Vol. 27, No. 1, 01.2010, p. 27-38.

Research output: Contribution to journalArticle

He, Huan ; Nilsson, Carol L. ; Emmett, Mark ; Ji, Yongjie ; Marshall, Alan G. ; Kroes, Roger A. ; Moskal, Joseph R. ; Colman, Howard ; Lang, Frederick F. ; Conrad, Charles A. / Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan. In: Glycoconjugate Journal. 2010 ; Vol. 27, No. 1. pp. 27-38.
@article{d6df4e14e46c4402a995481c07fb495f,
title = "Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan",
abstract = "We report changes in gene and polar lipid expression induced by adenovirus-delivered wild-type (wt) p53 gene and chemotherapy of U87 MG glioblastoma cells, a treatment known to trigger apoptosis and cell cycle arrest. Sulfatides (sulfonated glycolipids) were most highly modulated by wild-type p53 treatment; however, no changes were observed in expression levels of mRNA for genes involved in sulfatide metabolism, indicating post-transcriptional control of sulfatide synthesis. Modulation of the aglycones of GD1 and GM1b was observed in wild-type p53-treated cells. The treatment also leads to an increase in phospholipids such as phosphatidyl inositols, phosphatidyl serines, phosphatidyl glycerols, and phosphatidyl ethanolamines, especially hydroxylated phospholipids. These dramatic changes in the composition of cellular glycolipids in response to p53 gene expression and cytotoxic chemotherapy treatment indicate the large role that they play in cell signaling. The use of the human glioma cell line U87 appears to be an excellent model system both in tissue culture and in intracranial murine xenograft models to further characterize the role of sulfatides in modulating glioma responsivity to therapeutic agents.",
keywords = "Fourier transform ion cyclotron resonance mass spectrometry, Galectin-1, Glioblastoma, Glycolipids, Lipidomics, Microarrays, Phospholipids, Sulfatides",
author = "Huan He and Nilsson, {Carol L.} and Mark Emmett and Yongjie Ji and Marshall, {Alan G.} and Kroes, {Roger A.} and Moskal, {Joseph R.} and Howard Colman and Lang, {Frederick F.} and Conrad, {Charles A.}",
year = "2010",
month = "1",
doi = "10.1007/s10719-009-9249-6",
language = "English (US)",
volume = "27",
pages = "27--38",
journal = "Glycoconjugate Journal",
issn = "0282-0080",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, Irinotecan

AU - He, Huan

AU - Nilsson, Carol L.

AU - Emmett, Mark

AU - Ji, Yongjie

AU - Marshall, Alan G.

AU - Kroes, Roger A.

AU - Moskal, Joseph R.

AU - Colman, Howard

AU - Lang, Frederick F.

AU - Conrad, Charles A.

PY - 2010/1

Y1 - 2010/1

N2 - We report changes in gene and polar lipid expression induced by adenovirus-delivered wild-type (wt) p53 gene and chemotherapy of U87 MG glioblastoma cells, a treatment known to trigger apoptosis and cell cycle arrest. Sulfatides (sulfonated glycolipids) were most highly modulated by wild-type p53 treatment; however, no changes were observed in expression levels of mRNA for genes involved in sulfatide metabolism, indicating post-transcriptional control of sulfatide synthesis. Modulation of the aglycones of GD1 and GM1b was observed in wild-type p53-treated cells. The treatment also leads to an increase in phospholipids such as phosphatidyl inositols, phosphatidyl serines, phosphatidyl glycerols, and phosphatidyl ethanolamines, especially hydroxylated phospholipids. These dramatic changes in the composition of cellular glycolipids in response to p53 gene expression and cytotoxic chemotherapy treatment indicate the large role that they play in cell signaling. The use of the human glioma cell line U87 appears to be an excellent model system both in tissue culture and in intracranial murine xenograft models to further characterize the role of sulfatides in modulating glioma responsivity to therapeutic agents.

AB - We report changes in gene and polar lipid expression induced by adenovirus-delivered wild-type (wt) p53 gene and chemotherapy of U87 MG glioblastoma cells, a treatment known to trigger apoptosis and cell cycle arrest. Sulfatides (sulfonated glycolipids) were most highly modulated by wild-type p53 treatment; however, no changes were observed in expression levels of mRNA for genes involved in sulfatide metabolism, indicating post-transcriptional control of sulfatide synthesis. Modulation of the aglycones of GD1 and GM1b was observed in wild-type p53-treated cells. The treatment also leads to an increase in phospholipids such as phosphatidyl inositols, phosphatidyl serines, phosphatidyl glycerols, and phosphatidyl ethanolamines, especially hydroxylated phospholipids. These dramatic changes in the composition of cellular glycolipids in response to p53 gene expression and cytotoxic chemotherapy treatment indicate the large role that they play in cell signaling. The use of the human glioma cell line U87 appears to be an excellent model system both in tissue culture and in intracranial murine xenograft models to further characterize the role of sulfatides in modulating glioma responsivity to therapeutic agents.

KW - Fourier transform ion cyclotron resonance mass spectrometry

KW - Galectin-1

KW - Glioblastoma

KW - Glycolipids

KW - Lipidomics

KW - Microarrays

KW - Phospholipids

KW - Sulfatides

UR - http://www.scopus.com/inward/record.url?scp=77949261632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949261632&partnerID=8YFLogxK

U2 - 10.1007/s10719-009-9249-6

DO - 10.1007/s10719-009-9249-6

M3 - Article

C2 - 19557511

AN - SCOPUS:77949261632

VL - 27

SP - 27

EP - 38

JO - Glycoconjugate Journal

JF - Glycoconjugate Journal

SN - 0282-0080

IS - 1

ER -